PCH PREGNANCY TEST FHC-P103P-ONC45

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04,08 report with the FDA on 2013-09-06 for PCH PREGNANCY TEST FHC-P103P-ONC45 manufactured by Alere San Diego, Inc.

Event Text Entries

[3931171] Caller reported potential false negative urine hcg test with pch pregnancy test. A consumer purchased pch pregnancy test for his wife on (b)(6) 2013. He stated the packaging was closed and his wife took the first test that day and a second test on (b)(6) 2013 using a urine cup. Both tests gave negative results. He said that his wife continued to fell sick so they purchased some cold medications, nyquil being one of them but still felt sick so they went to the doctor. The doctor confirmed that she was six weeks pregnant (date of testing and confirmation method not provided). This complaint initially reported to (b)(4) in (b)(6) but there was a delay in forwarding it to alere.
Patient Sequence No: 1, Text Type: D, B5


[11227795] Retain testing: lot number (s) 2ev0588. Expiration date (s): 04/2014. Control lot: 25miu/ml hcg urine control lot: hcg130627-01. 100miu/ml hcg urine control lot: hcg130130-01. Summary of results: the retention devices meet qc specification. Details as below: correct positive results were observed when tested with 25miu/ml hcg urine control at 3 minute read time. (n=29). Corrective positive results were observed when tested with 100miu/ml hcg urine control at 3 minute read time. (n=5). All the c lines and minus lines appeared within 90 seconds meeting specifications for line intensity at the 3 minute read time. Conclusion: from retain testing with in-house controls, the client's result was not replicated, and the product performed as expected meeting qc specifications. Verified the product number, product description, lot number and batch record; no abnormal results were found. Summary of results: the return device meets qc specification. Details as below: correct positive results were observed when tested with 25miu/ml hcg urine control at 3 minutes read time. (n=1). The c line and minus line appeared within 90 seconds meeting specifications for line intensity at 3 minutes read time. Conclusion. From return testing with in-house control, the client's result was not replicated, and the product performed as expected. Customer's observation was nor replicated in-house with retention and returned devices. Retention devices were tested with cutoff hcg urine control (25miu/ml) and mid-level hcg urine control (100 miu/ml). All results were positive at read time. Customer only returned 1 device. Returned device was tested with ctoff hcg urine control and result was positive at read time. No false negatives were obtained. Mfg batch record review did not uncover any abnormalities. Root cause could not be determined without pt sample in-house analysis. Product deficiency was not established. This issue will be tracked and trended. No corrective action required at this time as no product deficiency was established.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2027969-2013-00791
MDR Report Key3373669
Report Source04,08
Date Received2013-09-06
Date of Report2013-08-13
Date of Event2013-01-24
Date Mfgr Received2013-08-13
Date Added to Maude2013-09-30
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactYA-LING KING
Manufacturer Street9975 SUMMERS RIDGE RD
Manufacturer CitySAN DIEGO CA 92121
Manufacturer CountryUS
Manufacturer Postal92121
Manufacturer Phone8588052084
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePCH PREGNANCY TEST
Generic NameHCG PREGNANCY TEST
Product CodeLCX
Date Received2013-09-06
Returned To Mfg2013-08-23
Model NumberFHC-P103P-ONC45
Lot Number2EV0588
OperatorLAY USER/PATIENT
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerALERE SAN DIEGO, INC
Manufacturer AddressSAN DIEGO CA US


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2013-09-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.